Tailoring pH-responsive acrylic acid microgels with hydrophobic crosslinks for drug release [PDF]
Amphiphilic microgels based on the hydrophilic acrylic acid (AA) and hydrophobic crosslinks of different compositions were synthesised using a lab-on-a-chip device. The microgels were formed by polymerising hydrophobic droplets.
Georgiou, T. K. +3 more
core +2 more sources
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Poly(lactic acid) (PLA) is an aliphatic polyester considered a “green” material due to its natural-based origin and biodegradable properties. This is why PLA fibres may be compared with poly(ethylene terephthalate) (PET) fibres in an effort to partially ...
Smaro S. Lykidou +4 more
doaj +1 more source
Mechanism of cellular uptake of genotoxic silica nanoparticles. [PDF]
Mechanisms for cellular uptake of nanoparticles have important implications for nanoparticulate drug delivery and toxicity. We have explored the mechanism of uptake of amorphous silica nanoparticles of 14 nm diameter, which agglomerate in culture medium ...
Brown, AP +5 more
core +3 more sources
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Blends of Polyethylene Terephthalate (PET) and Nanostructured Hyperbranched Polyesteramide for Improvement the Dyeability of PET: Thermodynamics [PDF]
Incorporating Hybrane H1500 as a nanostructured hyperbranched polyesteramide into polyethylene terephthalate (PET) enhances the dyeability of PET with C.I. Disperse Blue 56. The results show that the disperse dye display much greater substantivity toward
Ahani, M. +4 more
core
Textiles screen-printed with photochromic ethyl cellulose-spirooxazine composite nanoparticles [PDF]
Photochromic compounds change colour on exposure to light, while the reversion may be attributable either to radiation or may be thermal. The use of photochromism on fabrics can provide new opportunities to develop smart textiles; for example, sensors ...
Feczkó, Tivadar +2 more
core +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta +10 more
wiley +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source

